| Name | Title | Contact Details |
|---|
CASI Pharmaceuticals, Inc. (NASDAQ:CASI) is a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing cancer and other unmet medical needs for the global market with a primary focus on China. Our mission is to become an integrated biopharmaceutical company with significant market share in China, while establishing partnerships for global development and commercialization. Part of our strategy is to leverage our expertise and resources in North America and China to bring safer, more effective, and/or easier-to-use drugs to patients and to develop them more cost-effectively and faster using our unique dual development approach.
Dynavax Technologies Corporation is a biopharmaceutical company that discovers and develops a pipeline of Toll-like Receptor (TLR) product candidates.
Founded in 1975, CHS is the industry's trusted provider of onsite health centers and national examination programs.
Kaiser Permanente is a physician-led medical group in Northern and Central California that provides quality medical care to over 3.8 million members. They practice a multi-lingual, culturally inclusive approach to care that celebrates the diversity of ...
Athena Diagnostics, Inc. is a commercial diagnostic laboratory focused on performing esoteric tests, which the Company refers to as assays, primarily in the field of neurology.